Bextra Plaintiffs Blast Summary Judgment Motion

Law360, New York (April 11, 2008, 12:00 AM EDT) -- As Pfizer Inc. geared up for the first trials in multidistrict litigation over its arthritis drugs Celebrex and Bextra, plaintiffs rebuffed the drug company's bid for summary judgment and defended their use of expert testimony last week.

On Friday, the plaintiffs in the MDL blasted Pfizer's March 31 motion for summary judgment in one of the bellwether cases, brought by Beverly Haslam on behalf of her husband, whose fatal heart attack was allegedly brought on by taking Bextra.

The plaintiffs said Pfizer's ÔÇťarguments are largely frivolous...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.